P0DOX5 (IGG1_HUMAN) Homo sapiens (Human)

Immunoglobulin gamma-1 heavy chain UniProtKBInterProInteractive Modelling

449 aa; Sequence (Fasta)

Available Structures

76 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of Bevacizumab Fab mutant in complex with VEGF
6bft
 Heteromer
P15692; Q8TCD0; 		1-226
2×SO4; 2×MES;
Assess
Crystal Structure of a Broadly Neutralizing Anti-HIV-1 Antibody in Complex with a Peptide Mimotope
1n0x
 Heteromer
P01834; 		1-222
8×GOL; 4×SO4; 1×CXS; 1×K;
Assess
Bovine Fab 2G3
8ecq
 Heteromer
P0DOY2; 		1-222
3×GOL; 1×MES;
Assess
Bovine Fab 5C1
8ed1
 Heteromer
P0DOY2; 		1-222
3×GOL; 1×PO4;
Assess
Bovine Fab 4C1
8ecz
 Heteromer
P0DOY2; 		1-222
2×PO4;
Assess
Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex
6oge
 Heteromer
P01834; P04626; Q6GMX6; 		1-222
1×NAG; 5×NAG;
Assess
Structure of a mutant Cetuximab Fab fragment
6arp
 Heteromer
Q8TCD0; 		1-221
3×SO4; 5×GOL;
Assess
human GIPR ECD and Fab complex
6dkj
 Heteromer
P48546; V9HW34; 		1-221
Assess
Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (s…
3pgf
 Heteromer
P0AEX9; Q8TCD0; 		2-222
1×GLC; 2×IMD; 2×GOL;
Assess
Anti-HIV-1 Fab 2G12 re-refinement
6n32
 Heteromer
P0DOX7; 		1-221
5×SO4;
Assess
Crystal structure of crenezumab Fab
5vzx
 Heteromer
Q0KKI6; 		1-221
11×SO4; 2×MES; 2×EPE;
Assess
Anti-HIV-1 Fab 2G12 + Man5 re-refinement
6mub
 Heteromer
P0DOX7; 		1-221
2×BMA;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
7czv
 Heteromer
P01594; P0DP02; P0DTC2; Q8TCD0; 		1-221
20×NAG; 31×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
7czu
 Heteromer
P01594; P0DP02; P0DTC2; Q8TCD0; 		1-221
21×NAG; 28×NAG;
Assess
Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement
6n35
 Heteromer
P0DOX7; 		1-220
1×MAN; 1×BEZ; 1×GOL; 1×MAN;
Assess
Bovine Fab 2F12
8ecv
 Heteromer
P0DOY2; 		1-220
Assess
Crystal structure of crenezumab Fab in complex with Abeta
5vzy
 Heteromer
P05067; Q0KKI6; 		1-220
Assess
Anti-HIV-1 Fab 2G12 + Man9 re-refinement
6n2x
 Heteromer
P0DOX7; 		1-220
2×NAG;
Assess
VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure
6v8z
 Heteromer
Q2N0S6; Q2N0S7; Q6N089; Q6P5S8; Q8N5F4; 		1-220
27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG;
Assess
RBD in complex with Fab14
7xxl
 Heteromer
P0DTC2; 		1-220
1×NAG;
Assess
3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide
6uoe
 Heteromer
P06473; P0DOX7; 		1-219
1×TRS; 1×PEG;
Assess
Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement
6msy
 Heteromer
P0DOX7; 		1-219
2×MAN; 8×UNX; 2×ACT;
Assess
Anti-HIV-1 Fab 2G12 + Man7 re-refinement
6mu3
 Heteromer
P0DOX7; 		1-219
2×BMA;
Assess
Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain
6aru
 Heteromer
P00533; Q8TCD0; 		1-219
1×NAG; 1×NAG; 3×NAG;
Assess
Crystal structure of the SF12 Fab
6okq
 Heteromer
Q8TCD0; 		1-219
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-…
6bf9
 Heteromer
P0DOX7; P14735; 		1-219
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-…
6b70
 Heteromer
P01308; P14735; Q6GMX0; 		1-219
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11 heavy chain and FAB H11…
6b7z
 Heteromer
P14735; Q6GMX0; 		1-219
Assess
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-…
6bf7
 Heteromer
P0DOX7; P14735; 		1-219
Assess
Crystal structure of human Fab PGT124, a broadly neutralizing and potent HIV-1 neutralizing antibody
4r26
 Heteromer
P0DOY3; 		2-219
3×GOL;
Assess
Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neut…
6bkb
 Heteromer
B9V0E2; Q6PIL8; 		3-220
1×NAG; 3×NAG;
Assess
Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4
4r2g
 Heteromer
P01730; P0DOY3; P20871; 		2-219
1×NAG; 8×NAG; 1×CL; 1×GOL;
Assess
Bovine Fab SKD in complex with Sars COV-2 receptor binding domain
8edf
 Heteromer
P0DOY2; P0DTC2; 		2-219
1×NAG;
Assess
Crystal structure of the complex between afucosylated/galactosylated human IgG1 Fc and Fc gamma rec…
5vu0
 Heteromer
P08637; 		230-446
2×NAG; 5×EDO; 4×PEG; 9×NA; 2×NAG;
Assess
Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain
6bgt
 Heteromer
P04626; Q7Z3Y4; 		1-217
1×NAG;
Assess
BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195
5vj6
 Heteromer
Q2N0S6; Q6GMW3; Q8TCD0; S6B291; 		3-219
Assess
N123-VRC34.05 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519
6ubi
 Heteromer
P04578; Q6GMX0; 		4-219
Assess
Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neut…
6bkc
 Heteromer
B9V0E2; Q8TCD0; 		4-219
4×NAG;
Assess
Model of gC1q-Fc complex based on 7A EM map
6fcz
 Heteromer
P02745; P02746; P02747; 		234-449
Assess
Crystal structure of fucosylated IgG1 Fc complexed with bis-glycosylated soluble form of Fc gamma r…
5xje
 Heteromer
P08637; 		232-446
2×NAG; 1×NAG; 1×NAG; 1×CL;
Assess
Crystal structure of fucosylated IgG Fc Y296W mutant complexed with bis-glycosylated soluble form o…
5xjf
 Heteromer
P08637; 		232-446
2×NAG; 1×NAG; 1×CL; 1×NAG;
Assess
Crystal structure of the low affinity Fc gamma receptor IIIA variant in complex with the Fc of IgG1.
7uru
 Heteromer
P08637; 		234-446
2×NAG; 2×NAG;
Assess
Crystal structure of human IgG-Fc in complex with aglycan and optimized Fc gamma receptor IIIa
5yc5
 Heteromer
P08637; 		234-446
1×NAG; 1×NAG; 1×CL;
Assess
Glycosylated FCGR3B / CD16b in complex with afucosylated IgG1 Fc
6eaq
 Heteromer
O75015; 		235-446
1×NAG; 1×NAG; 2×NAG;
Assess
Crystal structure of VEGF in complex with heterodimeric Fcab JanusCT6
5o4e
 Heteromer
P15692; 		238-448
2×NAG; 1×MAN; 1×NAG; 10×MPD; 1×MRD; 2×CAC; 1×TRS;
Assess
GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT
6ytb
 Heteromer
239-447
2×NAG;
Assess
Fc in complex with engineered calcium binding domain Z
6fgo
 Heteromer
A0A0U3TLJ6; 		239-447
2×NAG; 5×PEG; 7×GOL; 2×CA; 5×CL;
Assess
GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT
6yt7
 Heteromer
P01857; 		239-446
2×NAG;
Assess
GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT
6ysc
 Heteromer
239-446
2×NAG;
Assess
Crystal structure of an IgM rheumatoid factor YES8c in complex with IgG1 Fc
5xmh
 Heteromer
239-446
1×NAG;
Assess
The complex structure of Human IgG Fc and its binding Repebody
6ka7
 Heteromer
240-447
2×NAG;
Assess
BEAT Fc with improved heterodimerization (Q3A-D84.4Q)
6g1e
 Heteromer
P01857; P01860; 		239-445
2×NAG;
Assess
Endoglycosidase S in complex with IgG1 Fc
8a49
 Heteromer
Q99Y92; 		240-446
1×NAG;
Assess
cryoEM structure of the catalytically inactive EndoS from S. pyogenes in complex with the Fc region…
8a64
 Heteromer
Q99Y92; 		239-445
1×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P2B-1A10
7czq
 Heteromer
A0A5C2GF00; P01594; P0DTC2; Q8TCD0; 		99-221
21×NAG; 28×NAG;
Assess
S protein of SARS-CoV-2 in complex bound with P5A-2G9
7czt
 Heteromer
A0A5C2GMM2; P01772; P0DTC2; Q8N5F4; 		99-221
21×NAG; 28×NAG;
Assess
Cryo-EM structure of the circumsporozoite protein of Plasmodium falciparum with a vaccine-elicited …
6mb3
 Heteromer
Q7K740; 		2-119
Assess
Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425
6apd
 Heteromer
A0A0B4J1V1; P03420; Q6GMX4; Q6GMX6; Q8TCD0; 		109-220
Assess
Zika Virus asymmetric unit bound with IgM antibody DH1017 Fab fragment
7t17
 Heteromer
A0A024B7W1; B9A064; 		120-224
Assess
Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV…
8dao
 Heteromer
P01834; P0DTC2; 		120-222
Assess
CryoEM structure of Hantavirus ANDV Gn(H) protein complex with 2Fabs ANDV-5 and ANDV-34
8dbz
 Heteromer
P01834; Q9E006; 		120-222
Assess
Structure of IgG-Fc hexamer
7x13
homo-12-mer238-443
Assess
Crystal structure of human IgG1-Sigma Fc fragment
5w5l
homo-2-mer237-446
2×NAG;
Assess
Crystal structure of a human fucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana)
6vsl
homo-2-mer237-446
2×NAG; 2×MPD;
Assess
Structure of bispecific Fc
6ifj
homo-2-mer237-446
2×NAG; 5×GOL;
Assess
NNAS Fc mutant
6x3i
homo-2-mer238-446
2×NAG; 2×BMA;
Assess
Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decis…
5wav
homo-2-mer239-447
2×NAG; 3×GOL;
Assess
Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A
6bz4
homo-2-mer239-446
1×NAG; 1×NAG; 1×EDO;
Assess
Crystal structure of a human afucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamian…
6vsz
homo-2-mer238-445
2×NAG;
Assess
Fc mutant (K392D/K409D/D399K)
5y56
homo-2-mer238-445
1×NAG; 1×NAG;
Assess
Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered …
6ugw
homo-2-mer239-445
2×NAG; 6×ZN; 2×ACT;
Assess
Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative o…
6ugx
homo-2-mer239-445
1×NAG; 1×NAG; 1×K; 1×CL;
Assess
HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT
6p6d
homo-2-mer240-446
2×NAG; 2×CYS;
Assess
X-ray crystal structure of Fc and peptide complex
6iqg
homo-2-mer239-445
2×NAG; 1×CL;
Assess
X-ray crystal structure of covalent-bonded complex of Fc and peptide
6iqh
homo-2-mer239-445
2×NAG;
Assess
Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative ort…
6ugy
homo-2-mer240-445
2×NAG; 6×ZN; 2×ACT;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2ig2.1.Bmonomer0.761-231
90.63
Assess
8a64.1.Bmonomer0.68239-445
100.00
Assess